solifenacin succinate
solifenacin succinate is listed in the FDA National Drug Code directory with 22 NDC codes, marketed under brand names including solifenacin succinate, VESIcare, Solifenacin succinate. Available dosage forms: tablet, coated, tablet, film coated, tablet, film coated, extended release, powder, suspension.
Drug details
- Generic Name
- solifenacin succinate
- Brand Names
- solifenacin succinate, VESIcare, Solifenacin succinate, VESIcare LS, Solifenacin Succinate
- Application Number
- ANDA204374
- Sponsor
- Macleods Pharmaceuticals Limited
- NDC Codes
- 22
- Dosage Forms
- TABLET, COATED, TABLET, FILM COATED, TABLET, FILM COATED, EXTENDED RELEASE, POWDER, SUSPENSION
- Routes
- ORAL
- Active Ingredients
- SOLIFENACIN SUCCINATE
Indications and Usage
1 INDICATIONS AND USAGE Solifenacin succinate is indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate is a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. ( 1 )